申请人:Furukubo Shigeru
公开号:US20090182140A1
公开(公告)日:2009-07-16
An alicyclic heterocyclic compound represented by the following formula or a pharmaceutically acceptable salt thereof:
wherein ring A is a heterocyclic ring, ring B is a carbocyclic ring, a heterocyclic ring etc., P
1
and P
2
are CH or N, q and r are 0 to 2, X is —NH—, —O—, —CH
2
—, etc., Y is —CH
2
—, —CO—, —SO
2
—, etc., Z is —CO—, —SO
2
—, etc., and R
3
is carbocyclic group, heterocyclic group, hydroxyl, alkoxy or amino,
is useful as a controlling agent of the function of CCR
4
useful for the prevention or treatment for bronchial asthma, atopic dermatitis, etc.
以下式子所示的脂环杂环化合物或其药学上可接受的盐:
其中环A为杂环,环B为碳环,杂环等,P1和P2为CH或N,q和r为0至2,X为—NH—,—O—,—CH2—等,Y为—CH2—,—CO—,—SO2—等,Z为—CO—,—SO2—等,R3为碳环基团,杂环基团,羟基,烷氧基或氨基,用作CCR4功能调节剂,用于预防或治疗支气管哮喘,特应性皮炎等。